Skip to content
Subscriber Only

Risk of Unprotected Sex Debated in Gilead HIV Pill Review

Healthy people can protect themselves from the deadly HIV virus if they take Gilead Sciences Inc.’s Truvada every day. Whether patients will is an issue dividing AIDS advocates as U.S. regulators weigh approving the pill as the first preventative measure against the disease.

Truvada is safe and effective enough as a preventative medicine, Food and Drug Administration staff concluded in a report yesterday. An advisory panel recommendation for approval, set for debate tomorrow, hinges on who would get the pill and whether patients can be educated on the importance of following through with a prescription.